Q4 2022 Holdings
Filed 2023-02-14 | 46 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $170.4M | 1,315,000 | 13.2% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $137.7M | 7,566,292 | 10.7% |
| Eqrx Inc | COM | 26886C107 | $97.2M | 39,527,669 | 7.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $86.7M | 365,000 | 6.7% |
| Illumina Inc(ILMN) | COM | 452327109 | $77.8M | 385,000 | 6.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $64.7M | 1,477,800 | 5.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $60.1M | 2,525,000 | 4.7% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $51.9M | 9,505,000 | 4.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $45.3M | 3,030,648 | 3.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $44.3M | 2,290,571 | 3.4% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $36.2M | 1,300,000 | 2.8% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $32.4M | 1,675,000 | 2.5% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $31.6M | 12,604,275 | 2.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $28.0M | 565,000 | 2.2% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $23.0M | 2,270,000 | 1.8% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $22.5M | 945,000 | 1.7% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $21.5M | 475,000 | 1.7% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $20.7M | 2,050,000 | 1.6% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $18.9M | 850,000 | 1.5% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $17.3M | 1,850,000 | 1.3% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $16.8M | 9,038,388 | 1.3% |
| Prometheus Biosciences Inc | COM | 74349U108 | $16.5M | 150,000 | 1.3% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $16.4M | 3,206,380 | 1.3% |
| Absci Corporation(ABSI) | COM | 00091E109 | $15.5M | 7,363,260 | 1.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $14.5M | 370,000 | 1.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $14.0M | 630,000 | 1.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $13.6M | 734,350 | 1.1% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $12.2M | 6,078,860 | 0.9% |
| Moderna Inc(MRNA) | COM | 60770K107 | $10.8M | 60,000 | 0.8% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $10.3M | 295,000 | 0.8% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $8.1M | 50,000 | 0.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $6.8M | 200,000 | 0.5% |
| Incyte Corp(INCY) | COM | 45337C102 | $6.2M | 77,500 | 0.5% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $5.4M | 30,000 | 0.4% |
| Dice Therapeutics Inc | COM | 23345J104 | $5.1M | 165,000 | 0.4% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $4.5M | 100,000 | 0.4% |
| Optimizerx Corp(OPRX) | COM NEW | 68401U204 | $4.4M | 260,000 | 0.3% |
| Sema4 Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $4.3M | 16,437,500 | 0.3% |
| Definitive Healthcare Corp(DH) | CLASS A COM | 24477E103 | $4.0M | 360,000 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.9M | 510,882 | 0.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.1M | 65,000 | 0.2% |
| Singular Genomics Systems in | COM | 82933R100 | $2.7M | 1,345,722 | 0.2% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.4M | 200,000 | 0.1% |
| Exscientia PLC | ADS | 30223G102 | $1.1M | 213,900 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $338.5K | 206,415 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $200.6K | 123,839 | 0.0% |